A New Paradigm for Protein Design and Biological Self-Assembly.

about

Transferred NOESY NMR studies of biotin mimetic peptide (FSHPQNT) bound to streptavidin: a structural model for studies of peptide-protein interactions.The fluorous effect in biomolecular applications.Position-dependent impact of hexafluoroleucine and trifluoroisoleucine on protease digestion.

P2860

Q35046198-E0233D8D-93CB-424B-BA54-38A20AE8F2AE Q37892383-0583A133-C224-41F8-B098-08D02D33E9E6 Q52725083-89BF3965-E569-47D3-9DE5-DC6C5180F1FE

P2860

A New Paradigm for Protein Design and Biological Self-Assembly.

Item

http://www.wikidata.org/entity/Q42686673

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

A New Paradigm for Protein Design and Biological Self-Assembly.

@en

A New Paradigm for Protein Design and Biological Self-Assembly.

@nl

type

Item

label

A New Paradigm for Protein Design and Biological Self-Assembly.

@en

A New Paradigm for Protein Design and Biological Self-Assembly.

@nl

prefLabel

A New Paradigm for Protein Design and Biological Self-Assembly.

@en

A New Paradigm for Protein Design and Biological Self-Assembly.

@nl

P1476

A New Paradigm for Protein Design and Biological Self-Assembly.

@en

P2093

Gizem Akçay

http://www.w3.org/2001/XMLSchema#string

Krishna Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic applications of fluorous solid-phase extraction (F-SPE)

Perspective on fluorocarbon chemistry

Modulating protein structure with fluorous amino acids: increased stability and native-like structure conferred on a 4-helix bundle protein by hexafluoroleucine.

Stabilization of bzip peptides through incorporation of fluorinated aliphatic residues.

A coiled coil with a fluorous core.

Enrichment and analysis of peptide subsets using fluorous affinity tags and mass spectrometry.

Mechanisms of antimicrobial peptide action and resistance.

Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.

Glucagon-like peptide 1(GLP-1) in biology and pathology.

Converting a peptide into a drug: strategies to improve stability and bioavailability.

P304

1178-1182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JFLUCHEM.2009.09.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41453216

http://www.w3.org/2001/XMLSchema#string

P698

20161419

http://www.w3.org/2001/XMLSchema#string

P921

protein design

self-assembly

P932

2786179

http://www.w3.org/2001/XMLSchema#string

A New Paradigm for Protein Design and Biological Self-Assembly.

about

P2860

P2860

A New Paradigm for Protein Design and Biological Self-Assembly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932